No definition available.
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
87 |
4. Check minimum number of eventsNone |
87 |
5. Include endpointsNone |
87 |
6. Filter based on genotype QC (FinnGen only) |
78 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 78 | 34 | 44 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 78.48 | 78.22 | 78.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 81
- Matched controls
- 810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
113.6
80
*
L57.0
ICD-10 Finland
Actinic keratosis
10.6
26.3
48
98
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
27.4
21.1
29
16
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.9
18.9
30
50
CBA10
NOMESCO Finland
Biopsy of eyelid
42.3
14.2
17
5
TQW99
NOMESCO Finland
Other minor procedure on skin
12.0
13.3
25
29
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
152.7
12.8
13
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
21.1
11.8
17
10
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
25.8
11.2
15
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.4
11.1
29
76
ZXC15
NOMESCO Finland
Use of photodynamic technique
18.0
10.0
15
10
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
13.1
9.9
17
16
S21
ICPC
Skin texture symptom/complaint
4.8
9.4
28
81
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.3
9.3
35
121
ZXC50
NOMESCO Finland
Cryotherapy
8.9
8.5
18
25
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
8.5
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.6
8.2
24
68
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.0
7.6
19
47
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
10.3
7.4
14
16
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
11.6
7.3
13
13
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
75.6
6.5
7
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
12.5
6.5
11
10
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
9.8
6.3
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
39
153
3.99
8.61
2.5
1.9
—
—
—
0
0
19
51
4.56
6.83
2.4
1.8
—
—
—
0
0
14
30
5.41
4.97
3.4
1.9
—
—
—
0
0
34
164
2.85
4.86
3.4
2.2
—
—
—
0
0
57
364
2.91
4.68
6.4
4.6
34.88
34.33
g/l
0.34
52
338
17
57
3.51
4.43
1.5
1.6
—
—
—
0
0
39
213
2.60
4.26
2.6
2.3
3.36
2.99
mg/l
0.20
34
186
53
337
2.66
4.21
2.9
2.4
88.79
92.81
pmol/l
0.31
37
170
18
66
3.22
4.08
3.6
4.5
109.00
95.55
ng/l
0.18
13
57
12
29
4.67
3.89
2.9
1.8
—
—
—
0
0
25
114
2.73
3.86
2.0
1.8
—
—
—
0
0
24
108
2.74
3.79
2.0
1.9
—
—
—
0
0
74
600
3.70
3.65
34.7
21.2
34.88
24.24
mg/l
1.29
66
528
8
14
6.21
3.43
1.5
1.4
—
—
—
0
0
46
294
2.31
3.33
3.7
2.7
—
—
estimate
—
0
0
65
484
2.74
3.33
5.7
4.9
18.67
15.41
mm/h
0.57
60
444
61
441
2.55
3.32
5.9
5.3
7.07
6.86
mmol/l
0.37
61
419
46
296
2.28
3.26
2.5
2.4
—
—
—
0
0
47
306
2.28
3.22
2.7
2.8
78.01
77.96
nmol/l
0.00
42
269
15
57
3.00
3.17
3.3
7.3
25.32
24.80
mmol/l
0.22
15
57
6
9
7.09
2.92
1.2
1.6
—
—
—
0
0
8
18
4.81
2.87
1.4
1.2
—
—
—
0
0
8
18
4.81
2.87
1.4
1.2
—
—
—
0
0
25
131
2.31
2.81
4.3
3.5
0.78
1.08
e6/l
0.37
17
69
14
55
2.87
2.79
3.7
9.5
93.41
93.23
%
0.05
14
55
74
624
3.15
2.76
39.4
25.9
3.98
4.02
mmol/l
0.57
74
610
74
624
3.15
2.76
38.3
25.8
139.12
139.50
mmol/l
0.54
74
610
66
518
2.48
2.63
12.3
8.2
82.10
79.13
u/l
0.39
61
491
16
70
2.60
2.61
2.6
2.4
271.88
271.98
ng/l
0.00
16
61
74
629
3.04
2.59
43.5
28.4
98.78
87.84
umol/l
0.65
74
619
5
7
7.51
2.58
1.6
1.4
—
—
—
0
0
10
32
3.42
2.54
1.0
1.2
—
—
—
0
0
73
617
2.85
2.50
19.3
13.3
23.34
22.87
u/l
0.12
68
595
51
368
2.04
2.42
3.8
3.2
60.64
51.39
u/l
0.25
44
342
67
537
2.43
2.42
5.2
4.9
1.18
1.22
mmol/l
0.21
61
462
5
8
6.57
2.40
1.6
1.4
—
—
—
0
0
5
8
6.57
2.40
1.6
1.4
—
—
—
0
0
5
8
6.57
2.40
1.6
1.4
—
—
—
0
0
5
8
6.57
2.40
1.2
1.6
—
—
—
0
0
28
165
2.07
2.31
5.4
4.3
508.09
364.62
ng/l
0.11
22
146
31
190
2.02
2.30
3.6
3.2
395.12
358.44
umol/l
1.25
25
158
69
566
2.48
2.26
5.9
5.7
3.98
4.25
mmol/l
1.64
63
498
5
9
5.83
2.24
1.6
1.3
—
—
—
0
0
69
567
2.46
2.23
7.7
8.4
39.98
41.41
mmol/mol
0.60
63
522
70
585
2.45
2.07
7.0
6.7
2.18
2.38
mmol/l
1.35
64
514
17
86
2.24
2.03
3.3
7.9
112.35
118.60
g/l
0.62
17
86
23
132
2.04
2.01
4.3
3.7
1.40
2.18
e6/l
0.31
15
72
50
373
1.89
2.00
8.8
6.5
1.22
1.21
mmol/l
0.23
45
341
8
27
3.17
1.99
1.0
1.1
—
—
—
0
0
56
437
1.91
1.91
3.5
4.4
15.21
15.39
pmol/l
0.21
51
384
66
546
2.13
1.88
5.5
5.7
2.00
2.03
mu/l
0.08
60
477
53
409
1.86
1.84
9.7
7.1
1.21
1.21
mmol/l
0.01
47
352
11
49
2.44
1.72
2.0
2.1
1.19
1.39
g/l
0.56
11
42
11
49
2.44
1.72
2.1
3.9
52.40
49.86
ml/min/173m2
—
5
21
67
564
2.09
1.72
6.0
5.7
1.37
1.43
mmol/l
0.48
61
492
36
253
1.76
1.67
3.8
4.0
4.33
12.62
mg/mmol
1.79
28
162
41
300
1.74
1.64
5.4
3.7
—
—
—
0
0
5
14
3.73
1.64
2.2
3.6
—
—
—
0
0
7
26
2.85
1.62
1.7
1.2
—
—
—
0
0
9
41
2.34
1.42
3.8
8.7
14.60
15.04
%
—
9
41
41
310
1.65
1.39
4.1
3.5
2038.48
1722.87
ng/l
0.28
35
262
21
133
1.78
1.35
3.8
5.9
103.62
104.31
mmol/l
0.22
21
133
32
235
1.60
1.18
6.2
3.7
0.13
0.43
e6/l
1.93
26
176
7
32
2.30
1.11
4.0
2.5
—
—
—
0
0
20
132
1.68
1.11
3.8
3.1
19.28
21.21
%
0.34
20
124
5
21
2.47
1.10
2.6
1.9
—
—
—
0
0
20
134
1.65
1.05
3.7
3.1
2.23
2.20
g/l
0.10
20
122
0
30
0.00
0.99
0.0
2.2
—
4.27
—
0
25
27
198
1.55
0.98
4.0
3.2
33.07
35.13
u/l
0.18
27
187
14
88
1.71
0.91
4.1
3.9
2.80
9.40
ug/l
—
9
71
8
46
1.82
0.85
1.8
1.2
—
—
—
0
0
6
32
1.94
0.83
6.8
4.1
340.38
29.37
mg/l
—
6
27
6
32
1.94
0.83
6.8
4.0
170.28
86.02
mg/l
—
6
27
64
582
1.47
0.67
6.7
6.1
6.03
6.18
mmol/l
0.40
58
508
11
73
1.59
0.60
8.8
9.7
—
—
—
0
0
6
38
1.62
0.55
6.7
2.5
0.00
0.00
g/l
—
6
33
43
376
1.31
0.52
4.6
4.8
0.00
0.00
estimate
—
6
93
25
207
1.30
0.44
4.1
4.8
27.16
21.94
%
0.79
18
98
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
2.5
—
17.35
—
0
17
17
136
1.32
0.37
2.2
1.9
28.61
29.34
s
0.29
17
129
42
378
1.23
0.36
4.9
4.8
0.00
16.92
estimate
—
6
96
7
51
1.41
0.32
1.4
2.5
1.33
1.15
%
—
7
51
42
383
1.20
0.30
4.8
4.9
0.00
0.00
estimate
—
6
84
8
62
1.32
0.29
1.1
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
4.6
—
—
—
0
0
0
10
0.00
0.21
0.0
4.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
7
60
1.18
0.18
1.1
1.4
—
—
—
0
0
10
85
1.20
0.13
1.5
3.1
0.23
1.25
e6/l
—
10
80
35
330
1.11
0.12
6.2
5.0
34.28
47.94
ng/l
0.83
28
278
24
224
1.10
0.09
1.7
2.0
1.25
1.18
mmol/l
0.25
19
185
6
53
1.14
0.09
2.8
2.5
13.97
13.11
nmol/l
—
6
45
21
216
0.96
0.00
4.5
4.6
0.00
0.00
estimate
—
5
74
30
294
1.03
0.00
4.4
4.9
0.00
0.04
estimate
—
6
76
17
172
0.99
0.00
4.2
4.9
1.02
1.02
kg/l
—
9
115
0
5
0.00
-0.00
0.0
5.0
—
74.20
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
9.78
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.6
—
0.29
—
0
7
9
90
1.00
-0.00
4.6
3.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
336.63
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
59
1.02
-0.00
1.8
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
4.71
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).